Home › Funds › M28 Capital Management LP › PRQR
M28 Capital Management LP position in PRQR
PROQR THRAPEUTICS N V · Health Care
M28 Capital Management LP reported holding 599,793 shares of PRQR (PROQR THRAPEUTICS N V) in its Q3 2026 13F filing — a position valued at US$996K, representing 2.76% of its reported portfolio and ranking #7 among its reported holdings. M28 Capital Management LP has disclosed PRQR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How M28 Capital Management LP's PRQR position evolved
M28 Capital Management LP first disclosed a stake in PRQR in Q3 2023 at 1,910,600 shares (US$2.5M). The position peaked in Q4 2023 at 1,910,600 shares, worth US$3.8M. Across 13 filings, M28 Capital Management LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 599,793 shares valued at US$996K. Notable position changes include a 47% trim in Q1 2024 (shares fell 28% over the following quarter), a 41% trim in Q1 2026 (shares rose 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.91M | $2.48M | New |
| Q4 2023 | 1.91M | $3.78M | Hold |
| Q1 2024 | 1.02M | $2.33M | Reduce |
| Q2 2024 | 1.02M | $1.69M | Hold |
| Q3 2024 | 1.02M | $1.86M | Hold |
| Q4 2024 | 1.02M | $2.70M | Hold |
| Q1 2025 | 1.02M | $1.36M | Hold |
| Q2 2025 | 1.02M | $2.08M | Hold |
| Q3 2025 | 1.02M | $2.17M | Hold |
| Q4 2025 | 1.02M | $2.06M | Hold |
| Q1 2026 | 599.79K | $971.66K | Reduce |
| Q2 2026 | 599.79K | $1.12M | Hold |
| Q3 2026 | 599.79K | $995.66K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PRQR and 13F data
PRQR (PROQR THRAPEUTICS N V) is a Health Care company. 38 other funds we track also report a position in PRQR — the largest reported positions include Privium Fund Management B.V. (US$9.1M), Ikarian Capital, LLC (US$6.4M), HEIGHTS CAPITAL MANAGEMENT, INC (US$5.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PRQR
- Privium Fund Management B.V. 5.47M sh · $9.08M · Q3 2026
- Ikarian Capital, LLC 3.43M sh · $6.37M · Q2 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 2.76M sh · $5.14M · Q2 2026
- Kynam Capital Management, LP 1.57M sh · $2.91M · Q2 2026
- DAFNA Capital Management LLC 1.53M sh · $2.85M · Q2 2026
- Squadron Capital Management LLC 1.51M sh · $2.81M · Q2 2026
- Monaco Asset Management SAM 634.92K sh · $1.05M · Q3 2026
- Lynx1 Capital Management LP 521.41K sh · $969.83K · Q2 2026
More on M28 Capital Management LP
FAQ
How long has M28 Capital Management LP held PRQR?
M28 Capital Management LP has disclosed PRQR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is M28 Capital Management LP's current position in PRQR?
As of Q3 2026, M28 Capital Management LP holds 599.79K shares of PRQR (PROQR THRAPEUTICS N V), valued at $995.66K, representing 2.76% of its reported portfolio and ranking #7.
Has M28 Capital Management LP been buying or selling PRQR?
In the latest 13F filing (Q3 2026), M28 Capital Management LP held unchanged its position in PRQR. The position peaked in Q4 2023 at 1.91M shares.
Which other funds hold PRQR?
Other major institutional holders of PRQR include Privium Fund Management B.V., Ikarian Capital, LLC, HEIGHTS CAPITAL MANAGEMENT, INC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.